191 related articles for article (PubMed ID: 23879607)
1. Current status of carbapenemases in Latin America.
Maya JJ; Ruiz SJ; Blanco VM; Gotuzzo E; Guzman-Blanco M; Labarca J; Salles M; Quinn JP; Villegas MV
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):657-67. PubMed ID: 23879607
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of antimicrobial resistance in Gram negative bacilli from intensive care units in Colombia].
Hernández-Gómez C; Blanco VM; Motoa G; Correa A; Vallejo M; Villegas MV;
Biomedica; 2014 Apr; 34 Suppl 1():91-100. PubMed ID: 24968040
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
4. Carbapenemases: molecular diversity and clinical consequences.
Poirel L; Pitout JD; Nordmann P
Future Microbiol; 2007 Oct; 2(5):501-12. PubMed ID: 17927473
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of carbapenemases in Latin America and the Caribbean.
Escandón-Vargas K; Reyes S; Gutiérrez S; Villegas MV
Expert Rev Anti Infect Ther; 2017 Mar; 15(3):277-297. PubMed ID: 27915487
[TBL] [Abstract][Full Text] [Related]
6. Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
Nastro M; Ayora M; García S; Vay C; Famiglietti Á; Rodriguez CH
J Chemother; 2017 Jun; 29(3):150-153. PubMed ID: 27347714
[TBL] [Abstract][Full Text] [Related]
7. Carbapenemases: a worldwide threat.
Quinn JP
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):643-4. PubMed ID: 23879603
[No Abstract] [Full Text] [Related]
8. Update on the epidemiology of carbapenemases in Latin America and the Caribbean.
García-Betancur JC; Appel TM; Esparza G; Gales AC; Levy-Hara G; Cornistein W; Vega S; Nuñez D; Cuellar L; Bavestrello L; Castañeda-Méndez PF; Villalobos-Vindas JM; Villegas MV
Expert Rev Anti Infect Ther; 2021 Feb; 19(2):197-213. PubMed ID: 32813566
[TBL] [Abstract][Full Text] [Related]
9. [Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii].
Martínez JA
Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():31-4. PubMed ID: 27608310
[TBL] [Abstract][Full Text] [Related]
10. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.
Rapp RP; Urban C
Pharmacotherapy; 2012 May; 32(5):399-407. PubMed ID: 22488420
[TBL] [Abstract][Full Text] [Related]
11. [Gram-negative bacteriae with resistance to carbapenems].
Nordmann P
Med Sci (Paris); 2010 Nov; 26(11):950-9. PubMed ID: 21106177
[TBL] [Abstract][Full Text] [Related]
12. High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.
Titecat M; Liang X; Lee CJ; Charlet A; Hocquet D; Lambert T; Pagès JM; Courcol R; Sebbane F; Toone EJ; Zhou P; Lemaitre N
J Antimicrob Chemother; 2016 Oct; 71(10):2874-82. PubMed ID: 27330072
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond.
Boyle DP; Zembower TR
Urol Clin North Am; 2015 Nov; 42(4):493-505. PubMed ID: 26475946
[TBL] [Abstract][Full Text] [Related]
14. Carbapenemases: the versatile beta-lactamases.
Queenan AM; Bush K
Clin Microbiol Rev; 2007 Jul; 20(3):440-58, table of contents. PubMed ID: 17630334
[TBL] [Abstract][Full Text] [Related]
15. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
16. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods.
van der Zwaluw K; de Haan A; Pluister GN; Bootsma HJ; de Neeling AJ; Schouls LM
PLoS One; 2015; 10(3):e0123690. PubMed ID: 25798828
[TBL] [Abstract][Full Text] [Related]
17. [News of antibiotic resistance among Gram-negative bacilli in Algeria].
Baba Ahmed-Kazi Tani Z; Arlet G
Pathol Biol (Paris); 2014 Jun; 62(3):169-78. PubMed ID: 24819127
[TBL] [Abstract][Full Text] [Related]
18. [Multiresistant Gram-negative bacterial infections: Enterobacteria, Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting Gram-negative bacilli].
Fariñas MC; Martínez-Martínez L
Enferm Infecc Microbiol Clin; 2013; 31(6):402-9. PubMed ID: 23684390
[TBL] [Abstract][Full Text] [Related]
19. [The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation].
Martínez-Martínez L; Calvo J
Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():25-31. PubMed ID: 21130927
[TBL] [Abstract][Full Text] [Related]
20. [Carbapenemases in enterobacteriaceae].
Nordmann P; Carrer A
Arch Pediatr; 2010 Sep; 17 Suppl 4():S154-62. PubMed ID: 20826325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
